Updated
Novo Nordisk A/SNVO · Healthcare
$40.31+0.02%
Market cap$135.3B
IndustryDrug Manufacturers - General
Novo Nordisk A/S (NVO) Superinvestor holders
29 of the superinvestors we track hold Novo Nordisk A/S (NVO) in their latest 13F filings, $3.7B in total.
Summary
The largest holder is Dodge & Cox, with $978M, 0.5% of the portfolio.
In their latest quarter: 6 opened a new position, 11 added, 10 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Dodge & Cox | Added | 20,397,110 | $978M | 0.5% | Q2 2026 |
| Aziz Hamzaogullari Loomis Sayles & Co |
Added | 18,594,352 | $891M | 1.1% | Q2 2026 |
| Arrowstreet Capital | Added | 8,270,785 | $397M | 0.2% | Q2 2026 |
| Ken Fisher Fisher Investments |
Trimmed | 7,949,470 | $301M | 0.1% | Q3 2026 |
| Alger Fred Alger Management |
New position | 4,907,570 | $235M | 0.8% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Trimmed | 3,032,421 | $145M | 0.2% | Q2 2026 |
| Fayez Sarofim Fayez Sarofim & Co |
Trimmed | 2,924,500 | $140M | 0.3% | Q2 2026 |
| Tom Steyer Farallon Capital Management LLC |
Added | 2,619,000 | $126M | 0.7% | Q2 2026 |
| Tom Gayner Markel Group Inc. |
Held | 2,869,774 | $109M | 0.8% | Q3 2026 |
| Paul Marshall Marshall Wace |
Trimmed | 1,707,104 | $82M | 0.1% | Q2 2026 |
| Sarah Ketterer Causeway Capital Management |
Added | 1,677,615 | $80M | 0.9% | Q2 2026 |
| Lee Ainslie Maverick Capital |
Trimmed | 1,653,872 | $79M | 0.7% | Q2 2026 |
| WCM Investment Management | Added | 1,181,027 | $57M | 0.1% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
Trimmed | 697,567 | $33M | 0.0% | Q2 2026 |
| Acadian Acadian Asset Management |
Trimmed | 847,980 | $32M | 0.0% | Q3 2026 |
| Mark Donovan Boston Partners |
Added | 507,489 | $24M | 0.0% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Added | 324,149 | $16M | 0.0% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
Trimmed | 182,382 | $9M | 0.0% | Q2 2026 |
| Hersh Cohen ClearBridge Investments |
Added | 67,393 | $3M | 0.0% | Q2 2026 |
| Eric Marshall Hodges Capital Management |
New position | 51,300 | $2M | 0.2% | Q2 2026 |
| Steve Cohen Point72 Asset Management |
New position | 29,198 | $1M | 0.0% | Q2 2026 |
| Ken Tropin Graham Capital Management |
New position | 29,113 | $1M | 0.1% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Trimmed | 15,800 | $757,452 | 0.0% | Q2 2026 |
| Murray Stahl Horizon Kinetics LLC |
Held | 15,350 | $735,879 | 0.0% | Q2 2026 |
| Alec Litowitz Magnetar Capital |
Added | 6,187 | $296,605 | 0.0% | Q2 2026 |
| Joel Greenblatt Gotham Asset Management |
New position | 4,758 | $228,099 | 0.0% | Q2 2026 |
| First Manhattan First Manhattan Co |
New position | 4,673 | $224,024 | 0.0% | Q2 2026 |
| Fred DiSanto Ancora Holdings |
Trimmed | 3,102 | $148,710 | 0.0% | Q2 2026 |
| Baillie Gifford Baillie Gifford & Co |
Added | 205 | $7,772 | 0.0% | Q3 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 29 |
| Q1 2026 | 27 |
| Q4 2025 | 26 |
| Q3 2025 | 26 |
| Q2 2025 | 29 |
| Q1 2025 | 31 |
| Q4 2024 | 29 |
| Q3 2024 | 32 |
Questions about Novo Nordisk A/S
Which superinvestors own Novo Nordisk A/S?
29 of the superinvestors we track hold Novo Nordisk A/S (NVO) in their latest 13F filings, $3.7B in total. Dodge & Cox, Aziz Hamzaogullari, Arrowstreet Capital, Ken Fisher, Alger, Jim Simons.
Who is the largest superinvestor holder of NVO?
The largest holder is Dodge & Cox, with $978M, 0.5% of the portfolio.
From Novo Nordisk A/S's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.